Ulrich Pichler is the director of Yokogawa’s Life Innovation Business (LIB) in Europe. In this blog, he explains the meaning and business vision of Life Science for Yokogawa.
Life Science – How Yokogawa contributes to Well-Being Read More »
The research team of Prof. Prisca Liberali at the Friedrich Miescher Institute for Biomedical Research (FMI) in Basel explored the potential of organoids for drug screening in a unique image-based screening approach assaying an annotated library of compounds to elucidate tissue regenerative mechanisms in organoids.
Organoids paving the way Read More »
At the end of 2019, the Yokogawa Life Innovation Business (LIB) reported on recent market strategies, product developments, and plans. Now at the beginning of the year 2021, even more great news occurred to be shared with our readers and customers in this business update article.
Further shaping the Life Innovation Business (LIB) Read More »
How do you develop new drugs? Here, Andreas Schamber describes the long path from research to the available drug.
The Path to a new Drug Read More »
Webinar: Professor Dr. Rafael Carazo Salas of the University of Bristol’s School of Cellular and Molecular Medicine will describe multicolor, multiday high-content microscopy pipelines that his research group has recently developed. These high-content microscopy pipelines are used to visualize the dynamic cell fate changes of human Pluripotent Stem Cells (hPSCs).
High-Content Imaging on Human Pluripotent Stem Cell Research Read More »
Read our interview with Prisca Liberali, Junior Group Leader at Friedrich Miescher Institute for Biomedical Research in Basel (Switzerland). At the same time, Prisca is also an Assistant Professor at the University of Basel. She talks about her passion for science and what she recommends women who’d like to pursue a career in science.
Don’t be afraid, be bold Read More »
Together with experts at InSphero and Yokogawa, we are hosting a webinar on January 14, 2021. In this webinar, we share our experience and advice for sample preparation, imaging, and analysis for both fixed and live-cell in high content screening assays.
High Content Imaging for 3D Spheroid Read More »
Yokogawa decided to support the world’s fight against COVID-19, scientifically cooperating with research facilities actively involved in COVID-19 research. In those global collaborations, researchers will use the Yokogawa bench-top confocal quantitative image cytometer – the CellVoyager CQ1 microscope.
Yokogawa supports COVID-19 research at the Charité in Berlin Read More »
InSphero and their pharma and biotech partners were eager to exploit the full potential of 3D models through interrogation of specific cell population interactions and extraction of spatial and temporal information. High Content Analysis (HCA), specifically high content imaging, was recognized as a key technology to accomplish these technically challenging goals.
The Future of High Content Analysis is 3D Read More »
